Rebecca A Marsh1, Jennifer W Leiding2, Brent R Logan3, Linda M Griffith4, Danielle E Arnold5, Elie Haddad6, E Liana Falcone7, Ziyan Yin3, Kadam Patel3, Erin Arbuckle8, Jack J Bleesing1, Kathleen E Sullivan5, Jennifer Heimall5, Lauri M Burroughs9, Suzanne Skoda-Smith10, Shanmuganathan Chandrakasan11, Lolie C Yu12, Benjamin R Oshrine13, Geoffrey D E Cuvelier14, Monica S Thakar9, Karin Chen15, Pierre Teira16, Shalini Shenoy17, Rachel Phelan18, Lisa R Forbes19, Deepak Chellapandian20, Blachy J Dávila Saldaña21, Ami J Shah22, Katja G Weinacht23, Avni Joshi24, Farid Boulad25, Troy C Quigg26, Christopher C Dvorak27, Debi Grossman28, Troy Torgerson29, Pamela Graham28, Vinod Prasad30, Alan Knutsen31, Hey Chong32, Holly Miller33, M Teresa de la Morena34, Kenneth DeSantes35, Morton J Cowan27, Luigi D Notarangelo36, Donald B Kohn37, Elizabeth Stenger38, Sung-Yun Pai39, John M Routes40, Jennifer M Puck27, Neena Kapoor41, Michael A Pulsipher41, Harry L Malech28, Suhag Parikh42, Elizabeth M Kang43. 1. Department of Pediatrics, University of Cincinnati, and Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 2. Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins-All Children's Hospital, University of South Florida, St. Petersburg, FL, USA. 3. Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA. 4. Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. 5. Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 6. Immunology-Rheumatology Division, Department of Pediatrics, University of Montreal, Montreal, QC, Canada. 7. Division of Immunity and Viral Infections, Institut de Recherches Cliniques de Montréal, Montréal, QC, Canada; and Department of Medicine, Université de Montréal, Montréal, QC, Canada. 8. Department of Pediatrics, Duke University, Durham, NC, USA. 9. Fred Hutchinson Cancer Research Center, Seattle Children's Hospital, The University of Washington School of Medicine, Seattle, WA, USA. 10. Seattle Children's Hospital, Seattle, WA, USA. 11. Division of Bone Marrow Transplant, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA. 12. Division of Hematology/Oncology and Hematopoietic Stem Cell Transplantation, The Center for Cancer and Blood Disorders, Children's Hospital/Louisiana State University Medical Center, New Orleans, LA, USA. 13. Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA. 14. Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada. 15. Division of Allergy and Immunology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. 16. CHU Sainte-Justine, Hematology-Oncology Division, Department of Pediatrics, University of Montreal, Montreal, QC, Canada. 17. Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, USA. 18. Pediatric Blood and Marrow Transplant Program, Division of Hematology, Oncology, and Blood and Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI, USA. 19. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA, and Section of Allergy, Immunology and Retrovirology, Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX, USA. 20. Blood and Marrow Transplant Program, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA. 21. Division of Blood and Marrow Transplantation, Children's National Medical Center, Washington, DC, USA, and Department of Pediatrics, The George Washington University, Washington, DC, USA. 22. Division of Stem Cell Transplantation and Regenerative Medicine, Stanford School of Medicine, Lucille Packard Children's Hospital, Palo Alto, CA, USA. 23. Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford School of Medicine, Stanford, CA, USA. 24. Division of Pediatric Allergy and Immunology, Mayo Clinic, Rochester, MN, USA. 25. Department of Pediatrics, BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 26. Texas Transplant Institute, Methodist Children's Hospital, San Antonio, TX, USA. 27. Pediatric Allergy, Immunology, and Blood and Marrow Transplant Division, San Francisco Benioff Children's Hospital, San Francisco, CA, USA. 28. Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. 29. Department of Pediatrics, Divisions of Immunology/Rheumatology, University of Washington and Seattle Children's Hospital, Seattle, WA, USA. 30. Division of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, NC, USA. 31. Pediatric Allergy and Immunology, Cardinal Glennon Children's Medical Center, Saint Louis University, St. Louis, MO, USA. 32. UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. 33. Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ, USA. 34. Department of Pediatrics/Immunology, University of Washington and Seattle Children's Hospital, Seattle, WA, USA. 35. American Family Children's Hospital, University of Wisconsin, Madison, WI, USA. 36. Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. 37. David Geffen School of Medicine at University of California, Los Angeles, CA, USA. 38. Aflac Center and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA. 39. Hematology-Oncology, Boston Children's Hospital, Boston, MA, USA. 40. Division of Allergy and Immunology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. 41. Blood and Marrow Transplant Program, Division of Hematology, Oncology and Blood and Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. 42. Division of Pediatric Blood and Marrow Transplant, Duke University, Durham, NC, USA. 43. Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. ekang@niaid.nih.gov.
Abstract
INTRODUCTION: Inflammatory bowel disease (IBD) affects approximately 1/3 of patients with chronic granulomatous disease (CGD). Comprehensive investigation of the effect of allogeneic hematopoietic cell transplantation (HCT) on CGD IBD and the impact of IBD on transplant outcomes is lacking. METHODS: We collected data retrospectively from 145 patients with CGD who had received allogeneic HCT at 26 Primary Immune Deficiency Treatment Consortium (PIDTC) centers between January 1, 2005 and June 30, 2016. RESULTS: Forty-nine CGD patients with IBD and 96 patients without IBD underwent allogeneic HCT. Eighty-nine percent of patients with IBD and 93% of patients without IBD engrafted (p = 0.476). Upper gastrointestinal acute GVHD occurred in 8.5% of patients with IBD and 3.5% of patients without IBD (p = 0.246). Lower gastrointestinal acute GVHD occurred in 10.6% of patients with IBD and 11.8% of patients without IBD (p = 0.845). The cumulative incidence of acute GVHD grades II-IV was 30% (CI 17-43%) in patients with IBD and 20% (CI 12-29%) in patients without IBD (p = 0.09). Five-year overall survival was equivalent for patients with and without IBD: 80% [CI 66-89%] and 83% [CI 72-90%], respectively (p = 0.689). All 33 surviving evaluable patients with a history of IBD experienced resolution of IBD by 2 years following allogeneic HCT. CONCLUSIONS: In this cohort, allogeneic HCT was curative for CGD-associated IBD. IBD should not contraindicate HCT, as it does not lead to an increased risk of mortality. This study is registered at clinicaltrials.gov NCT02082353.
INTRODUCTION:Inflammatory bowel disease (IBD) affects approximately 1/3 of patients with chronic granulomatous disease (CGD). Comprehensive investigation of the effect of allogeneic hematopoietic cell transplantation (HCT) on CGD IBD and the impact of IBD on transplant outcomes is lacking. METHODS: We collected data retrospectively from 145 patients with CGD who had received allogeneic HCT at 26 Primary Immune Deficiency Treatment Consortium (PIDTC) centers between January 1, 2005 and June 30, 2016. RESULTS: Forty-nine CGDpatients with IBD and 96 patients without IBD underwent allogeneic HCT. Eighty-nine percent of patients with IBD and 93% of patients without IBD engrafted (p = 0.476). Upper gastrointestinal acute GVHD occurred in 8.5% of patients with IBD and 3.5% of patients without IBD (p = 0.246). Lower gastrointestinal acute GVHD occurred in 10.6% of patients with IBD and 11.8% of patients without IBD (p = 0.845). The cumulative incidence of acute GVHD grades II-IV was 30% (CI 17-43%) in patients with IBD and 20% (CI 12-29%) in patients without IBD (p = 0.09). Five-year overall survival was equivalent for patients with and without IBD: 80% [CI 66-89%] and 83% [CI 72-90%], respectively (p = 0.689). All 33 surviving evaluable patients with a history of IBD experienced resolution of IBD by 2 years following allogeneic HCT. CONCLUSIONS: In this cohort, allogeneic HCT was curative for CGD-associated IBD. IBD should not contraindicate HCT, as it does not lead to an increased risk of mortality. This study is registered at clinicaltrials.gov NCT02082353.
Authors: Alexandra C Battersby; Helen Braggins; Mark S Pearce; Catherine M Cale; Siobhan O Burns; Scott Hackett; Stephen Hughes; Dawn Barge; David Goldblatt; Andrew R Gennery Journal: J Allergy Clin Immunol Date: 2017-03-23 Impact factor: 10.793
Authors: Fabian Hauck; Sibylle Koletzko; Christoph Walz; Horst von Bernuth; Anne Klenk; Irene Schmid; Bernd H Belohradsky; Christoph Klein; Philip Bufler; Michael H Albert Journal: J Crohns Colitis Date: 2015-10-13 Impact factor: 9.071
Authors: Beatriz E Marciano; Christa S Zerbe; E Liana Falcone; Li Ding; Suk See DeRavin; Janine Daub; Samantha Kreuzburg; Lynne Yockey; Sally Hunsberger; Ladan Foruraghi; Lisa A Barnhart; Kabir Matharu; Victoria Anderson; Dirk N Darnell; Cathleen Frein; Danielle L Fink; Karen P Lau; Debra A Long Priel; John I Gallin; Harry L Malech; Gulbu Uzel; Alexandra F Freeman; Douglas B Kuhns; Sergio D Rosenzweig; Steven M Holland Journal: J Allergy Clin Immunol Date: 2017-05-18 Impact factor: 10.793
Authors: Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin Journal: N Engl J Med Date: 2010-12-30 Impact factor: 91.245
Authors: Daniel J B Marks; Kana Miyagi; Farooq Z Rahman; Marco Novelli; Stuart L Bloom; Anthony W Segal Journal: Am J Gastroenterol Date: 2009-01 Impact factor: 10.864
Authors: Elena Soncini; Mary A Slatter; Laura B K R Jones; Stephen Hughes; Stephen Hodges; Terence J Flood; Dawn Barge; Gavin P Spickett; Graham H Jackson; Matthew P Collin; Mario Abinun; Andrew J Cant; Andrew R Gennery Journal: Br J Haematol Date: 2009-02-16 Impact factor: 6.998
Authors: L B K R Jones; P McGrogan; T J Flood; A R Gennery; L Morton; A Thrasher; D Goldblatt; L Parker; A J Cant Journal: Clin Exp Immunol Date: 2008-05 Impact factor: 4.330
Authors: D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas Journal: Bone Marrow Transplant Date: 1995-06 Impact factor: 5.483
Authors: Beatriz Morillo-Gutierrez; Rita Beier; Kanchan Rao; Lauri Burroughs; Ansgar Schulz; Anna-Maria Ewins; Brenda Gibson; Petr Sedlacek; Ladislav Krol; Brigitte Strahm; Irina Zaidman; Krzysztof Kalwak; Julie-An Talano; Ann Woolfrey; Chris Fraser; Isabelle Meyts; Ingo Müller; Jacek Wachowiak; Maria Ester Bernardo; Paul Veys; Karl-Walter Sykora; Andrew R Gennery; Mary Slatter Journal: Blood Date: 2016-05-23 Impact factor: 22.113
Authors: Brenna LaBere; Maria J Gutierrez; Hannah Wright; Elizabeth Garabedian; Hans D Ochs; Ramsay L Fuleihan; Elizabeth Secord; Rebecca Marsh; Kathleen E Sullivan; Charlotte Cunningham-Rundles; Luigi D Notarangelo; Karin Chen Journal: J Allergy Clin Immunol Pract Date: 2022-01-14
Authors: Sharat Chandra; Shanmuganathan Chandrakasan; Pooja Khandelwal; Rebecca A Marsh; Blachy J Dávila Saldaña; Jack J Bleesing; Michael B Jordan; Ashish R Kumar; Michael S Grimley; Christa Krupski; Stella M Davies Journal: J Clin Immunol Date: 2020-10-16 Impact factor: 8.317